PROC Relative Valuation - Procaps Group SA - Alpha Spread

Procaps Group SA
NASDAQ:PROC

Watchlist Manager
Procaps Group SA Logo
Procaps Group SA
NASDAQ:PROC
Watchlist
Price: 2.1612 USD -3.52% Market Closed
Market Cap: 243.8m USD
Have any thoughts about
Procaps Group SA?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of PROC.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PROC Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
78
Median 3Y
0.7
Median 5Y
0
Industry
2.6
Forward
0.6
vs History
33
vs Industry
41
Median 3Y
5.2
Median 5Y
0
Industry
22.9
Forward
6.7
vs History
53
vs Industry
46
Median 3Y
12.8
Median 5Y
4.7
Industry
17.6
vs History
vs Industry
16
Median 3Y
-49
Median 5Y
-75.6
Industry
25.2
vs History
28
vs Industry
10
Median 3Y
5.6
Median 5Y
-31.2
Industry
2.2
vs History
33
vs Industry
68
Median 3Y
1.1
Median 5Y
0
Industry
2.7
Forward
1
vs History
31
vs Industry
70
Median 3Y
2
Median 5Y
0
Industry
5.4
vs History
50
vs Industry
36
Median 3Y
11
Median 5Y
8.9
Industry
13.9
Forward
4.4
vs History
30
vs Industry
30
Median 3Y
13
Median 5Y
0
Industry
17.3
Forward
5.3
vs History
53
vs Industry
41
Median 3Y
15.2
Median 5Y
7.8
Industry
16.1
vs History
38
vs Industry
25
Median 3Y
14.9
Median 5Y
-29.9
Industry
18.8
vs History
63
vs Industry
51
Median 3Y
1.8
Median 5Y
1.4
Industry
2

Multiples Across Competitors

PROC Competitors Multiples
Procaps Group SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
LU
Procaps Group SA
NASDAQ:PROC
243.8m USD 0.6 4.7 8.6 13
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
LU
Procaps Group SA
NASDAQ:PROC
Average P/E: 32.1
4.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Discover More
Back to Top